Month: May 2020

YAVNE, Israel, May 13, 2020 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the first quarter ended March 31, 2020 at 7:00 am Eastern Time on Wednesday, May 20, 2020.Following the release, MediWound’s management will host a conference call and live webcast on Wednesday, May 20, 2020 at 8:30 am Eastern Time to discuss the financial results and to answer questions. Dial-in and call details are as follows:To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call.  An archived version of the webcast will be available for replay for 90 days in the Investors...

MALVERN, Pa., May 13, 2020 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leading producer of precision sensors and sensor-based systems, announced that the company will participate in the following upcoming virtual investor conferences:Baird Global Consumer, Technology, & Services Conference – Bill Clancy, CFO, is scheduled to present on June 4, 2020 at 1:25PM EDT. A live webcast, as well as the replay, of this presentation will be accessible from the Investors section of the VPG website at http://ir.vpgsensors.com/event. In addition, the company is available for one-on-one virtual meetings at the conference.Stifel 2020 Virtual Cross Sector Insight Conference – VPG will only be participating in virtual one-on-one meetings on June 9, 2020.For more information, or to schedule a one-on-one meeting with management,...

Key Financial HighlightsRevenue growth of 11.6 % over the same period of the previous fiscal year, reaching $36.1 M for the third quarter of fiscal year 2020;Gross profit margin before depreciation and amortization expenses represented 28.7 % of the Corporation’s total revenues for the third quarter of fiscal year 2020, compared to 23.3 % for the third quarter of previous fiscal year;Adjusted EBITDA1 reached $3.8 M, or 10.5 % of revenues, for the third quarter of fiscal year 2020 compared to $2.2 M, or 6.8 % of revenues, for the comparable quarter of previous fiscal year;Earnings of $1.6 M before non-recurring and non-cash impairment1 of $5.3 M for the three-month period ended March 31, 2020, compared to earnings of $0.5 M before impairment of nil for the comparable quarter of previous fiscal year;Net loss amounted to ($3.1 M) for the...

Faits saillantsCroissance soutenue des revenus de 11,6 %, par rapport à la même période de l’exercice financier précédent, pour atteindre 36,1 M $ pour le troisième trimestre de l’exercice financier 2020;Marge bénéficiaire brute avant amortissement représentant 28,7 % des revenus de la Société pour le troisième trimestre de l’exercice financier 2020, comparativement à 23,3 % pour le troisième trimestre de l’exercice financier précédent;BAIIA ajusté1 de 3,8 M $, ou 10,5 % des revenus, pour le troisième trimestre de l’exercice financier 2020, comparativement à 2,2 M $ ou 6,8 % des revenus, pour le trimestre comparable de l’exercice financier précédent;Bénéfice de 1,6 M $ avant dépréciation non-récurrente et hors trésorerie1 de 5,3 M $ pour la période de trois mois terminée le 31 mars 2020, comparativement à un bénéfice de 0,5 M $ avant...

CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that its chief executive officer, Jeff Goater, will present at the upcoming UBS Virtual Global Healthcare Conference, discussing Surface Oncology’s lead programs, SRF617 (targeting CD39) and SRF388 (targeting IL-27).The presentation will take place virtually on Wednesday, May 20, 2020 at 10 a.m. EDT. The live audio and subsequent archived webcasts of the Company’s presentations will be accessible from the Company’s investor relations website: investors.surfaceoncology.com.About Surface Oncology:Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor...

SACRAMENTO, CA, May 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Today BrewBilt Manufacturing Inc. (the “Company”) (OTCPINK: BBRW), announces that the company’s fundamentals in the brewery and cannabis industries continues to see steady growth. The company was assigned by a customer and has recently built a proprietary cannabis mini-coldwater extraction system for processing, with an order to build the first of several systems.The company has 5 customer breweries on track for delivery this summer, along with 7 new orders to manufacture for the remaining of the year.Jef Lewis, CEO, stated, “With COVID19, we have only seen an increase in our revenue and customer requests. It’s challenging times today for our country, and BrewBilt’s name continues to define quality craftsmanship in the design and manufacture of brewery and...

Canada’s average download speeds clocked at a blisteringly fast at 59.6 Mbps; South Korea’s networks at 59.0 MbpsUK-based Opensignal recorded download speeds for users on all three of Canada’s major operators with TELUS once again leading the pack by scoring an outstanding 75 MbpsTORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Canada’s 4G download speeds were heralded as fastest in the world, tied only with South Korea in Opensignal’s State of Mobile Network Experience 2020 report1. Most notably, Canada’s average 4G download speeds at 59.6 Mbps narrowly outpaced South Korea’s 5G networks at 59.0 Mbps respectively, signalling the strength of Canada’s global-leading mobile networks. In February 2020, Opensignal recorded download speeds for users on all three of Canada’s major operators and TELUS once again won this category by...

Kontaktperson:                                                                                                                                Adm. direktør                                                                                                                                Christian B. Lund                                                                                                                Tlf. 96 30 60 00Aalborg, den 13. maj 2020Bestyrelsen for Sanistål A/S meddeler, at Uffe Iversen den 14. maj 2020 tiltræder som ny økonomidirektør (CFO). Uffe Iversen vil udgøre selskabets direktion sammen med adm. direktør Christian B. Lund.Uffe Iversen afløser Flemming Glamann, der fratræder stillingen som økonomidirektør (CFO) dags dato.Bestyrelsesformand Anders K. Bønding siger om baggrunden for ændringen:”De seneste års restrukturering...

Fort Lauderdale, FL, May 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB: VFRM), a vertically-integrated agribusiness focused on the production of full spectrum hemp extracts with naturally occurring cannabinoids, is pleased to announce that it has partnered once again with Miami-based Toast Distillers, Inc., to address the growing need for hand sanitizers throughout the U.S. in response to the COVID-19 crisis.Veritas Farms will utilize its distribution network of over 6,000 stores and rapidly growing online presence to make readily available varying sizes and dispensers of the hand sanitizer produced locally by The Miami Distilling Company, a subsidiary of Toast Distillers, Inc.The hand sanitizer contains 70% isopropyl alcohol, aloe vera, and vitamin E. It will be available online beginning Monday,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Silver Viper Minerals Corp.  (“Silver Viper” or the “Company”) (TSX-V: VIPR) is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital and Red Cloud Securities Inc., as co-lead agents and joint bookrunners, acting on behalf of a syndicate of agents for the Company (the “Agents”), shall offer for sale up to 13,889,000 units of the Company (the “Units”) on a “best efforts” private placement basis, subject to all required regulatory approvals, at a price per Unit of C$0.36 (the “Issue Price”) for total gross proceeds of up to C$5,000,040 (the “Offering”).Each Unit shall consist of one common share of the Company (a “Share”)...